Please wait a minute...
文章检索
预防医学  2025, Vol. 37 Issue (10): 1039-1044    DOI: 10.19485/j.cnki.issn2096-5087.2025.10.013
  肿瘤流行病学专题 本期目录 | 过刊浏览 | 高级检索 |
2013—2022年南通市结直肠癌发病和死亡趋势分析
陈铭睿, 林玲, 楚楚, 黄捷, 韩亚蓉, 蔡波, 韩颖颖
南通市疾病预防控制中心,江苏 南通 226007
Trends in incidence and mortality of colorectal cancer in Nantong City from 2013 to 2022
CHEN Mingrui, LIN Ling, CHU Chu, HUANG Jie, HAN Yarong, CAI Bo, HAN Yingying
Nantong Center for Disease Control and Prevention, Nantong, Jiangsu 226007, China
全文: PDF(893 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解2013—2022年江苏省南通市结直肠癌发病和死亡趋势。方法 通过南通市肿瘤登记处收集2013—2022年南通市结直肠癌发病和死亡病例资料,计算结直肠癌粗发病率、粗死亡率、平均发病年龄和平均死亡年龄,采用2000年第五次全国人口普查标准人口年龄构成计算中国人口标化发病率(中标发病率)和中国人口标化死亡率(中标死亡率)、中标平均发病年龄和中标平均死亡年龄。采用平均年度变化百分比(AAPC)分析不同性别、年龄结直肠癌发病和死亡变化趋势,采用线性回归模型计算平均发病年龄和平均死亡年龄变化趋势。结果 2013—2022年南通市结直肠癌粗发病率和中标发病率分别从33.63/10万和16.05/10万上升至53.82/10万和19.62/10万,呈上升趋势(AAPC=5.665%和2.467%,均P<0.05);粗死亡率从2013年的15.99/10万上升至2022年的25.65/10万,呈上升趋势(AAPC=5.514%,P<0.05),中标死亡率趋势无统计学意义(P>0.05)。男性和女性结直肠癌中标发病率呈上升趋势(AAPC=2.666%和1.790%,均P<0.05),男性中标死亡率呈上升趋势(AAPC=1.966%,P<0.05),女性中标死亡率趋势无统计学意义(P>0.05)。40~<50岁、50~<60岁、60~<70岁、70~<80岁和≥80岁组结直肠癌粗发病率呈上升趋势(AAPC=4.045%、2.833%、2.300%、1.948%和1.775%,均P<0.05),≥80岁组粗死亡率呈上升趋势(AAPC=3.240%,P<0.05)。结直肠癌平均发病年龄年均增加0.156岁(P<0.05),中标平均发病年龄趋势无统计学意义(P>0.05);平均死亡年龄和中标平均死亡年龄分别年均增加0.325和0.153岁(均P<0.05)。结论 2013—2022年南通市结直肠癌粗发病率和粗死亡率均呈上升趋势,男性和≥40岁人群发病和死亡风险高,建议针对重点人群开展结直肠癌综合防治措施,降低结直肠癌疾病负担。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
陈铭睿
林玲
楚楚
黄捷
韩亚蓉
蔡波
韩颖颖
关键词 结直肠癌发病率死亡率平均年度变化百分比    
AbstractObjective To investigate trends in incidence and mortality of colorectal cancer in Nantong City, Jiangsu Province from 2013 to 2022. Methods Data on incidence and mortality of colorectal cancer from 2013 to 2022 in Nantong City were collected through the Nantong City cancer registry. The crude incidence, crude mortality, average age at onset, and average age at death of colorectal cancer were calculated. Chinese population-standardized incidence, Chinese population-standardized mortality, Chinese population-standardized average age at onset and Chinese population-standardized average age at death were calculated using the age structure of the standard population from the Fifth National Population Census in 2000. Trends in incidence and mortality of lung cancer from 2013 to 2022 were evaluated using average annual percent change (AAPC). Trends in the Chinese population-standardized average age at onset and Chinese population-standardized average age at death of lung cancer from 2013 to 2022 were evaluated using the linear regression model. Results From 2013 to 2022, the crude incidence and Chinese population-standardized incidence of colorectal cancer in Nantong City increased from 33.63/105 and 16.05/105 to 53.82/105 and 19.62/105, respectively, showing upward trends (AAPC=5.665% and 2.467%, both P<0.05). The crude mortality increased from 15.99/105 in 2013 to 25.65/105 in 2022, also showing an upward trend (AAPC=5.514%, P<0.05), while no statistically significant trend was found in the Chinese population-standardized mortality (P>0.05). The Chinese population-standardized incidence of colorectal cancer showed upward trends in both males and females (AAPC=2.666% and 1.790%, both P<0.05). The Chinese population-standardized mortality showed an upward trend in males (AAPC=1.966%, P<0.05), but no statistically significant trend was found in females (P>0.05). The crude incidence of colorectal cancer in the groups aged 40-<50 years, 50-<60 years, 60-<70 years, 70-<80 years, and ≥80 years showed upward trends (AAPC=4.045%, 2.833%, 2.300%, 1.948%, and 1.775%, all P<0.05), and the crude mortality in the group aged ≥80 years showed an upward trend (AAPC=3.240%, P<0.05). The average age at onset of colorectal cancer increased at an annual average of 0.156 years (P<0.05), while the trend in the Chinese population-standardized average age at onset was not statistically significant (P>0.05). The average age at death and the Chinese population-standardized average age at death increased at an annual average of 0.325 and 0.153 years, respectively (both P<0.05). Conclusions From 2013 to 2022, both the crude incidence and mortality of colorectal cancer in Nantong City showed upward trends. Males and individuals aged ≥40 years faced a higher risk of both incidence and mortality. It is recommended to implement comprehensive prevention and control measures targeting these high-risk populations to reduce the burden of colorectal cancer.
Key wordscolorectal cancer    incidence    mortality    average annual percent change
收稿日期: 2025-09-04      修回日期: 2025-09-22     
中图分类号:  R735.3  
基金资助:南通市卫生健康委员会科研课题(MS2023091,QNZ2023083)
作者简介: 陈铭睿,本科,医师,主要从事慢性非传染性疾病预防与控制工作
通信作者: 韩颖颖,E-mail:156967638@qq.com   
引用本文:   
陈铭睿, 林玲, 楚楚, 黄捷, 韩亚蓉, 蔡波, 韩颖颖. 2013—2022年南通市结直肠癌发病和死亡趋势分析[J]. 预防医学, 2025, 37(10): 1039-1044.
CHEN Mingrui, LIN Ling, CHU Chu, HUANG Jie, HAN Yarong, CAI Bo, HAN Yingying. Trends in incidence and mortality of colorectal cancer in Nantong City from 2013 to 2022. Preventive Medicine, 2025, 37(10): 1039-1044.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.10.013      或      http://www.zjyfyxzz.com/CN/Y2025/V37/I10/1039
[1] BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263.
[2] HAN B F,ZHENG R S,ZENG H M,et al.Cancer incidence and mortality in China,2022[J].J Natl Cancer Cent,2024,4(1):47-53.
[3] ZENG H M,CHEN W Q,ZHENG R S,et al.Changing cancer survival in China during 2003-15:a pooled analysis of 17 population-based cancer registries[J].Lancet Glob Health,2018,6(5):555-567.
[4] National Cancer Institute,USA.Cancer statistics explorer network[EB/OL].[2025-09-22].https://seer.cancer.gov/statistics-network/.2025.07.02.
[5] Japan Cancer Center.Cancer statistics in Japan-2023[EB/OL].[2025-09-22].https://ganjoho.jp/public/qa_links/report/statistics/2023_en.html.2023.03.31.
[6] 韩仁强,缪伟刚,俞浩,等.2020年江苏省恶性肿瘤发病和死亡现状分析[J].江苏预防医学,2024,35(5):568-574.
HAN R Q,MIAO W G,YU H,et al.Incidence and mortality analysis of cancers in Jiangsu Province in 2020[J].Jiangsu J Prev Med,2024,35(5):568-574.(in Chinese)
[7] 曾红梅,曹毛毛,郑荣寿,等.2000—2014年中国肿瘤登记地区肝癌发病年龄变化趋势分析[J].中华预防医学杂志,2018,52(6):573-578.
ZENG H M,CAO M M,ZHENG R S,et al.Trend analysis of age of diagnosis for liver cancer in cancer registry areas of China,2000-2014[J].Chin J Prev Med,2018,52(6):573-578.(in Chinese)
[8] 国家癌症中心.中国肿瘤登记工作指导手册(2016)[M].北京:人民卫生出版社,2016.
National Cancer Center.Chinese guideline for cancer registration(2016)[M].Beijing:People's Medical Publishing House,2016.(in Chinese)
[9] 南通市统计局.南通市第七次全国人口普查公报(第四号)——人口年龄构成情况[EB/OL].[2025-09-22].https://tjj.nantong.gov.cn/ntstj/tjgb/content/207c7940-dff2-47d9-89dd-cd939acfe4f8.html.2021.05.24.
Nantong Municipal Bureau of Statistics.Nantong seventh national population census bulletin(No.4):population age composition[EB/OL].[2025-09-22].https://tjj.nantong.gov.cn/ntstj/tjgb/content/207c7940-dff2-47d9-89dd-cd939acfe4f8.html.2021.05.24.(in Chinese)
[10] 宁思明,孙宝,晋亚楠,等.1990—2021年中国结直肠癌疾病负担研究及2022—2041年变化趋势分析[J].现代肿瘤医学,2025,33(9):1579-1587.
NING S M,SUN B,JIN Y N,et al.The disease burden of colon and rectum cancer in China from 1990 to 2021 and the predicted trends for 2022—2041[J].J Mod Oncol,2025,33(9):1579-1587.(in Chinese)
[11] 陈奇峰,陈康康,李金,等.2011—2019年绍兴市结直肠癌发病趋势分析[J].预防医学,2021,33(11):1146-1148.
CHEN Q F,CHEN K K,LI J,et al.Incidence trend of colorectal cancer in Shaoxing from 2011 to 2019[J].China Prev Med J,2021,33(11):1146-1148.(in Chinese)
[12] World Cancer Research Fund/American Institute for Cancer Research.The continuous update project expert report2017.Diet,nutrition,physical activity and colorectal cancer[R/OL].[2025-09-22].https://www.wcrf.org/wp-content/uploads/2024/10/Colorectal-cancer-report.pdf.
[13] 高菡璐,俞晓芳,吕乐彬,等.多靶点粪便DNA、肠道菌群、癌胚抗原及水果摄入对结直肠癌风险的交互作用研究[J].预防医学,2024,36(3):219-223,227.
GAO H L,YU X F,LYU L B,et al.Interactions of multi-target stool DNA,intestinal flora,carcinoembryonic antigen and fruit intake on the risk of colorectal cancer[J].China Prev Med J,2024,36(3):219-223,227.(in Chinese)
[14] 潘驰,孙晓晖,张增智,等.2014—2020年青岛市居民结直肠癌流行及疾病负担趋势分析[J].中华肿瘤防治杂志,2022,29(20):1439-1445.
PAN C,SUN X H,ZHANG Z Z,et al.Analysis for the trends of colorectal cancer epidemic and disease burden among Qingdao residents from 2014 to 2020[J].Chin J Cancer Prev Treat,2022,29(20):1439-1445.(in Chinese)
[15] 董学思,罗姿麟,雷林,等.男性结直肠癌超额发病风险中已知危险因素的解释效果分析[J].中国肿瘤,2021,30(12):901-904.
DONG X S,LUO Z L,LEI L,et al.Explanatory effects of known risk factors in excess incidence risk of colorectal cancer in men[J].China Cancer,2021,30(12):901-904.(in Chinese)
[16] SPAANDER M C W,ZAUBER A G,SYNGAL S,et al.Young-onset colorectal cancer[J].Nat Rev Dis Primers,2023,9(1):21.
[17] 练佳韦,刘颖春,余红平.结直肠癌的全球流行情况、危险因素及归因疾病负担研究进展[J].中国癌症防治杂志,2024,16(1):1-9.
LIAN J W,LIU Y C,YU H P.Colorectal cancer:global epidemiology,risk factors and advances in attributed disease burden[J].Chin J Oncol Prev Treat,2024,16(1):1-9.(in Chinese)
[18] 国家癌症中心中国结直肠癌筛查与早诊早治指南制定专家组.中国结直肠癌筛查与早诊早治指南(2020,北京)[J].中华肿瘤杂志,2021,43(1):16-38.
National Cancer Center,China,Expert Group of the Development of China Guideline for the Screening,Early Detection and Early Treatment of Colorectal Caneer.China guideline for the screening,early detection and early treatment of colorectal cancer(2020 Beijing)[J].Chin J Oncol,2021,43(1):16-38.(in Chinese)
[19] 马昭君,董建梅,柴莉莉,等.2008—2020年江苏省连云港市结直肠癌发病趋势及年龄变化特征分析[J].肿瘤学杂志,2025,31(8):689-696.
MA Z J,DONG J M,CHAI L L,et al.Trends of incidence and age at onset of colorectal cancer in Lianyungang City,Jiangsu Province from 2008 to 2020[J].J Chin Oncol,2025,31(8):689-696.(in Chinese)
[1] 李玉荣, 王冬飞, 高媛媛, 蒋园园, 林君英, 肖段段. 2010—2024年萧山区结直肠癌发病趋势分析[J]. 预防医学, 2025, 37(9): 927-931,936.
[2] 李君, 朱婷婷, 胡文雪. 2005—2023年温州市丙型病毒性肝炎流行特征分析[J]. 预防医学, 2025, 37(9): 932-936.
[3] 胡晓强, 刘艳, 周思凡, 张子喆, 王雨达, 沈建勇. 2014—2023年湖州市流行性感冒流行特征分析[J]. 预防医学, 2025, 37(9): 959-962.
[4] 李克, 庞志峰, 吴晓虹, 王诚, 何瑶, 唐慧玲. 2007—2024年金华市钩端螺旋体病流行特征分析[J]. 预防医学, 2025, 37(8): 818-821.
[5] 冷雪, 傅淑琴, 舒纪为, 谭启龙, 李科峰. 舟山市带状疱疹首诊病例特征分析[J]. 预防医学, 2025, 37(7): 701-704.
[6] 朱颖, 郑添. 2013—2023年嘉善县居民期望寿命变化[J]. 预防医学, 2025, 37(6): 598-602.
[7] 董沙沙, 项云飞. 2014—2023年余姚市原发性肝癌死亡与疾病负担分析[J]. 预防医学, 2025, 37(6): 603-607.
[8] 丁哲渊, 杨研, 傅天颖, 鲁琴宝, 王心怡, 吴昊澄, 刘魁, 林君芬, 吴晨. 2024年浙江省法定传染病疫情分析[J]. 预防医学, 2025, 37(5): 433-438,442.
[9] 任露露, 顾嘉昌, 闵艺璇, 张思晨, 乔健健, 肖月, 胡静. 2016—2023年宜兴市脑卒中发病趋势分析[J]. 预防医学, 2025, 37(5): 498-502.
[10] 李慧君, 叶振淼, 樊丽辉, 郑宇航, 谢轶敏, 姜雪霞, 高豪俊, 张默涵, 罗永园. 2015—2023年温州市老年人跌倒死亡趋势与减寿分析[J]. 预防医学, 2025, 37(5): 460-464.
[11] 周沁易, 马涛, 赵跃媛, 王恒学, 吴小清, 丁松宁, 苏晶晶. 2004—2022年南京市法定传染病发病趋势分析[J]. 预防医学, 2025, 37(5): 476-480.
[12] 王洪岩, 任飞林, 刘小琦, 金玫华, 吴振乾. 2009—2023年湖州市HIV/AIDS病例新发现率趋势分析[J]. 预防医学, 2025, 37(4): 395-399.
[13] 叶振淼, 樊丽辉, 姜雪霞, 郑宇航, 张默涵, 罗永园, 谢轶敏, 李慧君, 金茜. 2014—2023年温州市胃癌死亡及减寿趋势分析[J]. 预防医学, 2025, 37(3): 267-271.
[14] 张小乔, 张筱碟, 赵振希, 谢鹏留, 代敏. LSTM、SARIMA和SARIMAX模型预测手足口病发病率的效果比较[J]. 预防医学, 2025, 37(3): 280-284,287.
[15] 沈敏, 郁智慧, 朱爱韬. 1992—2021年中国慢性阻塞性肺疾病发病和死亡的年龄-时期-队列分析[J]. 预防医学, 2025, 37(2): 113-117.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed